
Global Opioid Narcotics Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Opioid Narcotics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Opioid Narcotics market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Opioid Narcotics market include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Opioid Narcotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Opioid Narcotics, also provides the sales of main regions and countries. Of the upcoming market potential for Opioid Narcotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioid Narcotics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Opioid Narcotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Opioid Narcotics sales, projected growth trends, production technology, application and end-user industry.
Opioid Narcotics Segment by Company
Yichang Renfu Pharmaceutical Co., Ltd.
Jiangsu Enhua Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co., Ltd.
Sinopharm Group Industrial Co., Ltd. Langfang Branch
Changzhou Siyao Pharmaceutical Co., Ltd.
Reig Jofre
Pfizer
GSK
Fresenius Kabi
Daiichi Sankyo
AcelRx Pharmaceuticals, Inc
Abbott
Opioid Narcotics Segment by Type
Fentanyl
Remifentanil
Sufentanil
Opioid Narcotics Segment by Application
Hospital
Clinic
Other
Opioid Narcotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Opioid Narcotics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Opioid Narcotics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Opioid Narcotics significant trends, drivers, influence factors in global and regions.
6. To analyze Opioid Narcotics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Opioid Narcotics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Opioid Narcotics industry.
Chapter 3: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Opioid Narcotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Opioid Narcotics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Opioid Narcotics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Opioid Narcotics market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Opioid Narcotics market include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Opioid Narcotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Opioid Narcotics, also provides the sales of main regions and countries. Of the upcoming market potential for Opioid Narcotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioid Narcotics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Opioid Narcotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Opioid Narcotics sales, projected growth trends, production technology, application and end-user industry.
Opioid Narcotics Segment by Company
Yichang Renfu Pharmaceutical Co., Ltd.
Jiangsu Enhua Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co., Ltd.
Sinopharm Group Industrial Co., Ltd. Langfang Branch
Changzhou Siyao Pharmaceutical Co., Ltd.
Reig Jofre
Pfizer
GSK
Fresenius Kabi
Daiichi Sankyo
AcelRx Pharmaceuticals, Inc
Abbott
Opioid Narcotics Segment by Type
Fentanyl
Remifentanil
Sufentanil
Opioid Narcotics Segment by Application
Hospital
Clinic
Other
Opioid Narcotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Opioid Narcotics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Opioid Narcotics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Opioid Narcotics significant trends, drivers, influence factors in global and regions.
6. To analyze Opioid Narcotics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Opioid Narcotics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Opioid Narcotics industry.
Chapter 3: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Opioid Narcotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Opioid Narcotics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
199 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Opioid Narcotics Sales Value (2020-2031)
- 1.2.2 Global Opioid Narcotics Sales Volume (2020-2031)
- 1.2.3 Global Opioid Narcotics Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Opioid Narcotics Market Dynamics
- 2.1 Opioid Narcotics Industry Trends
- 2.2 Opioid Narcotics Industry Drivers
- 2.3 Opioid Narcotics Industry Opportunities and Challenges
- 2.4 Opioid Narcotics Industry Restraints
- 3 Opioid Narcotics Market by Company
- 3.1 Global Opioid Narcotics Company Revenue Ranking in 2024
- 3.2 Global Opioid Narcotics Revenue by Company (2020-2025)
- 3.3 Global Opioid Narcotics Sales Volume by Company (2020-2025)
- 3.4 Global Opioid Narcotics Average Price by Company (2020-2025)
- 3.5 Global Opioid Narcotics Company Ranking (2023-2025)
- 3.6 Global Opioid Narcotics Company Manufacturing Base and Headquarters
- 3.7 Global Opioid Narcotics Company Product Type and Application
- 3.8 Global Opioid Narcotics Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Opioid Narcotics Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Opioid Narcotics Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Opioid Narcotics Market by Type
- 4.1 Opioid Narcotics Type Introduction
- 4.1.1 Fentanyl
- 4.1.2 Remifentanil
- 4.1.3 Sufentanil
- 4.2 Global Opioid Narcotics Sales Volume by Type
- 4.2.1 Global Opioid Narcotics Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Opioid Narcotics Sales Volume by Type (2020-2031)
- 4.2.3 Global Opioid Narcotics Sales Volume Share by Type (2020-2031)
- 4.3 Global Opioid Narcotics Sales Value by Type
- 4.3.1 Global Opioid Narcotics Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Opioid Narcotics Sales Value by Type (2020-2031)
- 4.3.3 Global Opioid Narcotics Sales Value Share by Type (2020-2031)
- 5 Opioid Narcotics Market by Application
- 5.1 Opioid Narcotics Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Opioid Narcotics Sales Volume by Application
- 5.2.1 Global Opioid Narcotics Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Opioid Narcotics Sales Volume by Application (2020-2031)
- 5.2.3 Global Opioid Narcotics Sales Volume Share by Application (2020-2031)
- 5.3 Global Opioid Narcotics Sales Value by Application
- 5.3.1 Global Opioid Narcotics Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Opioid Narcotics Sales Value by Application (2020-2031)
- 5.3.3 Global Opioid Narcotics Sales Value Share by Application (2020-2031)
- 6 Opioid Narcotics Regional Sales and Value Analysis
- 6.1 Global Opioid Narcotics Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Opioid Narcotics Sales by Region (2020-2031)
- 6.2.1 Global Opioid Narcotics Sales by Region: 2020-2025
- 6.2.2 Global Opioid Narcotics Sales by Region (2026-2031)
- 6.3 Global Opioid Narcotics Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Opioid Narcotics Sales Value by Region (2020-2031)
- 6.4.1 Global Opioid Narcotics Sales Value by Region: 2020-2025
- 6.4.2 Global Opioid Narcotics Sales Value by Region (2026-2031)
- 6.5 Global Opioid Narcotics Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Opioid Narcotics Sales Value (2020-2031)
- 6.6.2 North America Opioid Narcotics Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Opioid Narcotics Sales Value (2020-2031)
- 6.7.2 Europe Opioid Narcotics Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Opioid Narcotics Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Opioid Narcotics Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Opioid Narcotics Sales Value (2020-2031)
- 6.9.2 South America Opioid Narcotics Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Opioid Narcotics Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Opioid Narcotics Sales Value Share by Country, 2024 VS 2031
- 7 Opioid Narcotics Country-level Sales and Value Analysis
- 7.1 Global Opioid Narcotics Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Opioid Narcotics Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Opioid Narcotics Sales by Country (2020-2031)
- 7.3.1 Global Opioid Narcotics Sales by Country (2020-2025)
- 7.3.2 Global Opioid Narcotics Sales by Country (2026-2031)
- 7.4 Global Opioid Narcotics Sales Value by Country (2020-2031)
- 7.4.1 Global Opioid Narcotics Sales Value by Country (2020-2025)
- 7.4.2 Global Opioid Narcotics Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.9.2 France Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.16.2 China Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.19.2 India Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Opioid Narcotics Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Opioid Narcotics Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Opioid Narcotics Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Yichang Renfu Pharmaceutical Co., Ltd.
- 8.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Comapny Information
- 8.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
- 8.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Value and Gross Margin (2020-2025)
- 8.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
- 8.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
- 8.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
- 8.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Comapny Information
- 8.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview
- 8.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Value and Gross Margin (2020-2025)
- 8.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
- 8.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments
- 8.3 Henan Lingrui Pharmaceutical Co., Ltd.
- 8.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Comapny Information
- 8.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Business Overview
- 8.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Value and Gross Margin (2020-2025)
- 8.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
- 8.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments
- 8.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
- 8.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Comapny Information
- 8.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview
- 8.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Value and Gross Margin (2020-2025)
- 8.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio
- 8.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments
- 8.5 Changzhou Siyao Pharmaceutical Co., Ltd.
- 8.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Comapny Information
- 8.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview
- 8.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Value and Gross Margin (2020-2025)
- 8.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
- 8.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments
- 8.6 Reig Jofre
- 8.6.1 Reig Jofre Comapny Information
- 8.6.2 Reig Jofre Business Overview
- 8.6.3 Reig Jofre Opioid Narcotics Sales, Value and Gross Margin (2020-2025)
- 8.6.4 Reig Jofre Opioid Narcotics Product Portfolio
- 8.6.5 Reig Jofre Recent Developments
- 8.7 Pfizer
- 8.7.1 Pfizer Comapny Information
- 8.7.2 Pfizer Business Overview
- 8.7.3 Pfizer Opioid Narcotics Sales, Value and Gross Margin (2020-2025)
- 8.7.4 Pfizer Opioid Narcotics Product Portfolio
- 8.7.5 Pfizer Recent Developments
- 8.8 GSK
- 8.8.1 GSK Comapny Information
- 8.8.2 GSK Business Overview
- 8.8.3 GSK Opioid Narcotics Sales, Value and Gross Margin (2020-2025)
- 8.8.4 GSK Opioid Narcotics Product Portfolio
- 8.8.5 GSK Recent Developments
- 8.9 Fresenius Kabi
- 8.9.1 Fresenius Kabi Comapny Information
- 8.9.2 Fresenius Kabi Business Overview
- 8.9.3 Fresenius Kabi Opioid Narcotics Sales, Value and Gross Margin (2020-2025)
- 8.9.4 Fresenius Kabi Opioid Narcotics Product Portfolio
- 8.9.5 Fresenius Kabi Recent Developments
- 8.10 Daiichi Sankyo
- 8.10.1 Daiichi Sankyo Comapny Information
- 8.10.2 Daiichi Sankyo Business Overview
- 8.10.3 Daiichi Sankyo Opioid Narcotics Sales, Value and Gross Margin (2020-2025)
- 8.10.4 Daiichi Sankyo Opioid Narcotics Product Portfolio
- 8.10.5 Daiichi Sankyo Recent Developments
- 8.11 AcelRx Pharmaceuticals, Inc
- 8.11.1 AcelRx Pharmaceuticals, Inc Comapny Information
- 8.11.2 AcelRx Pharmaceuticals, Inc Business Overview
- 8.11.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Value and Gross Margin (2020-2025)
- 8.11.4 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio
- 8.11.5 AcelRx Pharmaceuticals, Inc Recent Developments
- 8.12 Abbott
- 8.12.1 Abbott Comapny Information
- 8.12.2 Abbott Business Overview
- 8.12.3 Abbott Opioid Narcotics Sales, Value and Gross Margin (2020-2025)
- 8.12.4 Abbott Opioid Narcotics Product Portfolio
- 8.12.5 Abbott Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Opioid Narcotics Value Chain Analysis
- 9.1.1 Opioid Narcotics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Opioid Narcotics Sales Mode & Process
- 9.2 Opioid Narcotics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Opioid Narcotics Distributors
- 9.2.3 Opioid Narcotics Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.